dalteparin has been researched along with Retinal Detachment in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Retinal Detachment: Separation of the inner layers of the retina (neural retina) from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. (Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed, p310-12).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the efficacy of a combination of 5-fluorouracil (5FU) and low-molecular-weight heparin (LMWH) in the treatment of unselected rhegmatogenous retinal detachment (RRD) undergoing primary vitrectomy." | 9.12 | Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy. ( Bunce, C; Charteris, DG; McGurn, D; Wickham, L; Wong, D, 2007) |
| "To determine the efficacy of a combination of 5-fluorouracil (5FU) and low-molecular-weight heparin (LMWH) in the treatment of unselected rhegmatogenous retinal detachment (RRD) undergoing primary vitrectomy." | 5.12 | Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy. ( Bunce, C; Charteris, DG; McGurn, D; Wickham, L; Wong, D, 2007) |
| "An 84-year-old woman with unstable angina pectoris was treated with subcutaneous enoxaparine (Clexane) for several days before presenting with severe pain and decreased vision in her left eye." | 1.31 | Massive choroidal hemorrhage associated with low molecular weight heparin therapy. ( Goldstein, M; Leibovitch, I; Loewenstein, A; Neudorfer, M, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Neudorfer, M | 1 |
| Leibovitch, I | 1 |
| Goldstein, M | 1 |
| Loewenstein, A | 1 |
| Schaub, F | 1 |
| Schiller, P | 1 |
| Hoerster, R | 1 |
| Kraus, D | 1 |
| Holz, FG | 1 |
| Guthoff, R | 1 |
| Agostini, H | 1 |
| Spitzer, MS | 1 |
| Wiedemann, P | 1 |
| Lommatzsch, A | 1 |
| Boden, KT | 1 |
| Dimopoulos, S | 1 |
| Bemme, S | 1 |
| Tamm, S | 1 |
| Maier, M | 1 |
| Roider, J | 1 |
| Enders, P | 1 |
| Altay, L | 1 |
| Fauser, S | 1 |
| Kirchhof, B | 1 |
| Wickham, L | 1 |
| Bunce, C | 1 |
| Wong, D | 1 |
| McGurn, D | 1 |
| Charteris, DG | 1 |
2 trials available for dalteparin and Retinal Detachment
| Article | Year |
|---|---|
Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy: Results from a Randomized Clinical Trial.
Topics: Dalteparin; Double-Blind Method; Fluorouracil; Heparin; Heparin, Low-Molecular-Weight; Humans; Retin | 2022 |
Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy.
Topics: Combined Modality Therapy; Cryotherapy; Dalteparin; Double-Blind Method; Drug Therapy, Combination; | 2007 |
1 other study available for dalteparin and Retinal Detachment
| Article | Year |
|---|---|
Massive choroidal hemorrhage associated with low molecular weight heparin therapy.
Topics: Acetazolamide; Aged; Aged, 80 and over; Angina, Unstable; Anticoagulants; Choroid Hemorrhage; Drug T | 2002 |